Genomic testing has the potential to assist diagnose, monitor, deal with, and stop illness, whereas selling good well being by way of all phases of an individual’s life. As genetic testing turns into extra extensively obtainable, the problem is to harness that info for scientific therapy.
Nest Genomics is creating a brand new software program platform that integrates genetic testing info into digital medical data, giving suppliers the flexibility to tell therapy choices with data-driven insights. The platform, launched within the final quarter, is already attracting curiosity from main U.S. well being techniques.
We invested in Nest Genomics as a result of its expertise will allow a affected person’s genetic check outcomes to routinely grow to be a part of their well being file — making certain that people and their docs have prepared entry to non-public genomic knowledge. Samsung Subsequent joined an $8.5 million seed spherical that additionally included Y Combinator, B Capital Group, DCVC, Maven Ventures, and Anne Wojcicki, co-founder of 23andme.
We have been impressed by the founder-market-fit for Nest Genomics. The corporate was co-founded by a dynamic married couple, who’re serial entrepreneurs. Moran Snir and her husband, Man Snir, co-founded Clear Genetics in 2017. They offered the corporate, a main developer of software program for offering genetic companies to sufferers, to Invitae Corp in 2019.
In the present day, Moran serves as Chief Govt Officer of Nest Genomics, and Man is the Chief Working Officer. Previous to launching Clear Genetics. Moran was concerned in selling genetic testing in Israel. She was beforehand a software program engineer for the Israeli army, studied biomedical engineering, and has an MBA from The Wharton College of the College of Pennsylvania, with a concentrate on healthcare administration. Man has held senior product roles at Twitter, SnappyTV, and Google’s Motorola subsidiary. He has a bachelor’s diploma in pc science and an MBA from Duke College.
The Nest Genomics platform integrates with current EMR techniques. As soon as a affected person’s genetic check outcomes come again from the lab, the Nest software program routinely generates a customized care plan. This facilitates supplier care choices and helps sufferers schedule follow-up appointments. For instance, a affected person in danger for breast most cancers would have a customized plan that features imaging, referrals to specialists, and proposals for remedy that may assist forestall most cancers.
The corporate’s preliminary go-to-market technique is to promote into well being techniques, with a concentrate on cardiology and oncology. Genetic testing is already getting used to evaluate and deal with sufferers in danger for coronary heart illness or most cancers. In 2020, for instance, the American Heart Association (AHA) really useful genetic testing to assist diagnose sufferers with a household historical past of coronary heart illness. The National Cancer Institute recommends genetic counseling and testing for at-risk sufferers and people with a hereditary most cancers danger.
Nest Genomics is well-positioned to grow to be a market chief in making genomic knowledge a part of mainstream therapy protocols. The market is presently at a tipping level, and the corporate’s platform might help meet a rising demand for genomic knowledge that can be utilized in scientific settings.
Lizzy Goldman is an Investor at Samsung Subsequent. Samsung Subsequent’s funding technique is restricted to its personal views and doesn’t mirror the imaginative and prescient or technique of another Samsung enterprise unit, together with, however not restricted, to Samsung Electronics.